Pacira BioSciences, Inc.
PCRX
$26.30
$0.311.19%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -125.66% | -46.41% | -35.50% | -1,421.29% | -26.69% |
| Total Depreciation and Amortization | 44.84% | 14.88% | 14.92% | 9.87% | -1.00% |
| Total Amortization of Deferred Charges | 10.94% | 22.98% | 22.43% | 21.89% | 9.32% |
| Total Other Non-Cash Items | 40.77% | -42.64% | 0.76% | 669.32% | 357.37% |
| Change in Net Operating Assets | -771.20% | -84.91% | -55.52% | 125.46% | 29.39% |
| Cash from Operations | -77.44% | -27.78% | -30.37% | 21.34% | 22.38% |
| Capital Expenditure | -69.62% | -201.41% | -17.80% | -20.57% | 53.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 576.04% | 97.01% | -82.80% | -4,970.78% | -226.98% |
| Cash from Investing | 508.56% | -65.03% | -104.39% | -1,101.36% | -307.68% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 98.15% | 0.00% | 0.00% | 89.89% | -7,096.84% |
| Issuance of Common Stock | 15.03% | -- | -18.00% | -100.00% | -58.07% |
| Repurchase of Common Stock | -118.00% | -4,425.00% | 27.36% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -330.20% | -6.28% | -9.89% | 89.76% | 5,577.27% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -73.22% | -77.77% | -43.13% | -108.84% | 22.89% |